Novus Therapeutics, Inc. Exchange Agreements

5 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Series X Exchange Agreement, dated December 31, 2020, by and among Novus Therapeutics, Inc. and the Stockholders named therein
Exchange Agreements
Novus Therapeutics, Inc.
Biotechnology
2021
Series X1 Exchange Agreement, dated January 11, 2022, by and among Eledon Pharmaceuticals, Inc. and the Stockholders named therein
Exchange Agreements
Novus Therapeutics, Inc.
Biotechnology
2022
Exchange Agreement, dated February 13, 2020, by and among Novus Therapeutics, Inc. and the Stockholders named therein
Exchange Agreements
Novus Therapeutics, Inc.
Biotechnology
2020
Pursuant to 17 CFR 20.24b-2, confidential information has been omitted in places marked ***and has been filed separately with the Securities and Exchange Commission pursuant to a...
Exchange Agreements
Novus Therapeutics, Inc.
Biotechnology
NY
2017
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. MASTER LICENSE AGREEMENT BETWEEN UNIVERSITY...
Exchange Agreements
Novus Therapeutics, Inc.
Biotechnology
NY
2014